Join to View Full Profile
37767 Market DrSt. Mary's Med. Ctr At Charlotte HallCharlotte Hall, MD 20622
Phone+1 301-475-5910
Are you Dr. Liu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ke Liu, MD is an oncologist in Charlotte Hall, Maryland.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1996 - 1999
Henan Medicine UniversityClass of 1984
Weill Cornell Medicine
Certifications & Licensure
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsAcquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M.Liang-Sheng Wang, Shi-Qi Chen, Xue Zhong, Xiao-Dong Jiao, Ke Liu
Anti-Cancer Drugs. 2023-11-01 - 11 citationsArsenic and cancer: Evidence and mechanisms.Rachel M Speer, Xixi Zhou, Lindsay B Volk, Ke Jian Liu, Laurie G Hudson
Advances in Pharmacology. 2023-01-01 - 11 citationsHSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy.Ke Liu, Jun Huang, Jiao Liu, Changfeng Li, Guido Kroemer
Cancer Research. 2022-05-16
Press Mentions
Marengo Therapeutics Appoints Ke Liu, MD, PhD, and Bruce Chabner, MD, to Key Leadership Roles, Strengthening Marengo's Development Team and Supporting Translation to the ClinicMay 9th, 2022- Alkermes Promotes from Within to Find New CFO and COO in Rebound Effort; Moderna Vet Robert Dolski Joins Checkmate as CFOJanuary 8th, 2021
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerNovember 21st, 2019- Join now to see all
